---
document_datetime: 2023-09-21 20:01:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/jorveza-epar-all-authorised-presentations_en.pdf
document_name: jorveza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6859358
conversion_datetime: 2025-12-28 02:21:40.416607
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                                                                                                                                                             | (Invented) name                                                                         | Strength                                                         | Pharmaceutical Form                                                                                                                                                                                                                               | Route of Administration                                                                            | Immediate Packaging                                                                                                                                                                                   | Pack size                                                                                                                    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|
| EU/1/17/1254/001 EU/1/17/1254/002 EU/1/17/1254/003 EU/1/17/1254/004 EU/1/17/1254/005 EU/1/17/1254/006 EU/1/17/1254/007 EU/1/17/1254/008 EU/1/17/1254/009 EU/1/17/1254/010 EU/1/17/1254/011 | Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza Jorveza | 1 mg 1 mg 1 mg 1 mg 1 mg 1 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg | Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet Orodispersible tablet | Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use | blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) blister (alu/alu) | 20 tablets 30 tablets 60 tablets 90 tablets 100 tablets 200 tablets 20 tablets 60 tablets 90 tablets 100 tablets 200 tablets |